For real-time updates on ALLK, beat the news and login or try Benzinga Pro.
Clinical-stage company Allakos ALLK today had a large opening gap of 49.18%.
Photo taken from the Opening Gap Signals tool inside Benzinga Pro.
Why Is ALLK Moving?
Allakos shares are trading higher after the company’s AK002 met all primary and secondary endpoints in its Phase 2 study. The company also reported better-than-expected Q2 EPS results.
Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.
For live updates on ALLK log in or try Benzinga Pro today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
